Cargando…

Patient-Guided Talking Points to Address COVID-19 and General Vaccine Hesitancy

Vaccination remains one of the most effective ways to limit spread of disease. Waning public confidence in COVID-19 vaccines has resulted in reduced vaccination rates. In fact, despite vaccine availability, many individuals choose to delay COVID-19 vaccination resulting in suboptimal herd immunity a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Elaine, Wright, Melanie, Oliphant, Cathy, Cleveland, Kevin, Holmes, John, Nies, Mary, Robinson, Renee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611272/
https://www.ncbi.nlm.nih.gov/pubmed/36287458
http://dx.doi.org/10.3390/pharmacy10050137
_version_ 1784819484822863872
author Nguyen, Elaine
Wright, Melanie
Oliphant, Cathy
Cleveland, Kevin
Holmes, John
Nies, Mary
Robinson, Renee
author_facet Nguyen, Elaine
Wright, Melanie
Oliphant, Cathy
Cleveland, Kevin
Holmes, John
Nies, Mary
Robinson, Renee
author_sort Nguyen, Elaine
collection PubMed
description Vaccination remains one of the most effective ways to limit spread of disease. Waning public confidence in COVID-19 vaccines has resulted in reduced vaccination rates. In fact, despite vaccine availability, many individuals choose to delay COVID-19 vaccination resulting in suboptimal herd immunity and increased viral mutations. A number of qualitative and quantitative studies have been conducted to identify, understand, and address modifiable barriers and factors contributing to COVID-19 vaccine hesitancy among individuals with access to vaccine. Vaccine confidence may be improved through targeted patient–provider discussion. More patients are turning to pharmacists to receive their vaccinations across the lifespan. The primary goal of this commentary is to share evidence-based, patient talking points, tailored by practicing pharmacists, to better communicate and address factors contributing to vaccine hesitancy and reduced vaccine confidence.
format Online
Article
Text
id pubmed-9611272
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96112722022-10-28 Patient-Guided Talking Points to Address COVID-19 and General Vaccine Hesitancy Nguyen, Elaine Wright, Melanie Oliphant, Cathy Cleveland, Kevin Holmes, John Nies, Mary Robinson, Renee Pharmacy (Basel) Opinion Vaccination remains one of the most effective ways to limit spread of disease. Waning public confidence in COVID-19 vaccines has resulted in reduced vaccination rates. In fact, despite vaccine availability, many individuals choose to delay COVID-19 vaccination resulting in suboptimal herd immunity and increased viral mutations. A number of qualitative and quantitative studies have been conducted to identify, understand, and address modifiable barriers and factors contributing to COVID-19 vaccine hesitancy among individuals with access to vaccine. Vaccine confidence may be improved through targeted patient–provider discussion. More patients are turning to pharmacists to receive their vaccinations across the lifespan. The primary goal of this commentary is to share evidence-based, patient talking points, tailored by practicing pharmacists, to better communicate and address factors contributing to vaccine hesitancy and reduced vaccine confidence. MDPI 2022-10-20 /pmc/articles/PMC9611272/ /pubmed/36287458 http://dx.doi.org/10.3390/pharmacy10050137 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
Nguyen, Elaine
Wright, Melanie
Oliphant, Cathy
Cleveland, Kevin
Holmes, John
Nies, Mary
Robinson, Renee
Patient-Guided Talking Points to Address COVID-19 and General Vaccine Hesitancy
title Patient-Guided Talking Points to Address COVID-19 and General Vaccine Hesitancy
title_full Patient-Guided Talking Points to Address COVID-19 and General Vaccine Hesitancy
title_fullStr Patient-Guided Talking Points to Address COVID-19 and General Vaccine Hesitancy
title_full_unstemmed Patient-Guided Talking Points to Address COVID-19 and General Vaccine Hesitancy
title_short Patient-Guided Talking Points to Address COVID-19 and General Vaccine Hesitancy
title_sort patient-guided talking points to address covid-19 and general vaccine hesitancy
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611272/
https://www.ncbi.nlm.nih.gov/pubmed/36287458
http://dx.doi.org/10.3390/pharmacy10050137
work_keys_str_mv AT nguyenelaine patientguidedtalkingpointstoaddresscovid19andgeneralvaccinehesitancy
AT wrightmelanie patientguidedtalkingpointstoaddresscovid19andgeneralvaccinehesitancy
AT oliphantcathy patientguidedtalkingpointstoaddresscovid19andgeneralvaccinehesitancy
AT clevelandkevin patientguidedtalkingpointstoaddresscovid19andgeneralvaccinehesitancy
AT holmesjohn patientguidedtalkingpointstoaddresscovid19andgeneralvaccinehesitancy
AT niesmary patientguidedtalkingpointstoaddresscovid19andgeneralvaccinehesitancy
AT robinsonrenee patientguidedtalkingpointstoaddresscovid19andgeneralvaccinehesitancy